GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (CHIX:DIAm) » Definitions » E10

Diasorin SpA (CHIX:DIAM) E10 : €3.88 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Diasorin SpA E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Diasorin SpA's adjusted earnings per share data for the three months ended in Mar. 2025 was €0.965. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €3.88 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Diasorin SpA's average E10 Growth Rate was 6.00% per year. During the past 3 years, the average E10 Growth Rate was 9.90% per year. During the past 5 years, the average E10 Growth Rate was 13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Diasorin SpA was 17.70% per year. The lowest was 9.90% per year. And the median was 13.80% per year.

As of today (2025-06-23), Diasorin SpA's current stock price is €93.00. Diasorin SpA's E10 for the quarter that ended in Mar. 2025 was €3.88. Diasorin SpA's Shiller PE Ratio of today is 23.97.

During the past 13 years, the highest Shiller PE Ratio of Diasorin SpA was 93.89. The lowest was 22.70. And the median was 42.51.


Diasorin SpA E10 Historical Data

The historical data trend for Diasorin SpA's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA E10 Chart

Diasorin SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.40 2.85 3.48 3.34 3.79

Diasorin SpA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.91 3.86 3.70 3.79 3.88

Competitive Comparison of Diasorin SpA's E10

For the Diagnostics & Research subindustry, Diasorin SpA's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Shiller PE Ratio falls into.


;
;

Diasorin SpA E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Diasorin SpA's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.965/122.5000*122.5000
=0.965

Current CPI (Mar. 2025) = 122.5000.

Diasorin SpA Quarterly Data

per share eps CPI Adj_EPS
201506 0.477 100.279 0.583
201509 0.420 100.000 0.515
201512 0.520 99.814 0.638
201603 0.449 99.600 0.552
201606 0.533 99.900 0.654
201609 0.524 100.100 0.641
201612 0.542 100.300 0.662
201703 0.601 101.000 0.729
201706 0.612 101.100 0.742
201709 0.535 101.200 0.648
201712 0.797 101.200 0.965
201803 0.691 101.800 0.832
201806 0.777 102.400 0.930
201809 0.656 102.600 0.783
201812 0.756 102.300 0.905
201903 0.739 102.800 0.881
201906 0.797 103.100 0.947
201909 0.780 102.900 0.929
201912 0.895 102.800 1.067
202003 0.688 102.900 0.819
202006 1.041 102.900 1.239
202009 1.238 102.300 1.482
202012 1.559 102.600 1.861
202103 1.428 103.700 1.687
202106 1.312 104.200 1.542
202109 1.448 104.900 1.691
202112 1.492 106.600 1.715
202203 1.503 110.400 1.668
202206 1.079 112.500 1.175
202209 1.152 114.200 1.236
202212 0.708 119.000 0.729
202303 0.785 118.800 0.809
202306 0.846 119.700 0.866
202309 0.469 120.300 0.478
202312 0.897 119.700 0.918
202403 0.862 120.200 0.878
202406 0.938 120.700 0.952
202409 0.844 121.200 0.853
202412 0.722 121.200 0.730
202503 0.965 122.500 0.965

Add all the adjusted EPS together and divide 10 will get our e10.


Diasorin SpA  (CHIX:DIAm) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Diasorin SpA's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=93.00/3.88
=23.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Diasorin SpA was 93.89. The lowest was 22.70. And the median was 42.51.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Diasorin SpA E10 Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines